Berg Announces Appointment Of As Chief Operating Officer Post author:Sam Post published:February 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Frost & Sullivan Release: Evolving Pharmaceutical Ecosystem Transforms Clinical Trials And Research Outsourcing June 15, 2017 Little-Known Synthorx Names Former Cleave CEO as New Leader November 27, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017
Frost & Sullivan Release: Evolving Pharmaceutical Ecosystem Transforms Clinical Trials And Research Outsourcing June 15, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017